(Circulation. 1999;99:2733-2736.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Relation Between Direct Detection of Chlamydia pneumoniae DNA in Human Coronary Arteries at Postmortem Examination and Histological Severity (Stary Grading) of Associated Atherosclerotic Plaque
From the Molecular Microbiology Group (M.T., M.E.W.) and Department of Pathology (P.J.G.), Southampton University Medical School (D.T., M.A.), Southampton, UK; Wessex Cardiothoracic Unit, Southampton General Hospital, Southampton, UK (Y.W.); and Great Ormond Street Children's Hospital, London, UK (V.T.)
Correspondence to Dr M. Thomas, Molecular Microbiology, Level C, South Block, Southampton General Hospital, Tremona Rd, Southampton SO16 6YD, UK. E-mail mt{at}soton.ac.uk
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Numerous studies have suggested a link between Chlamydia pneumoniae infection, atherosclerosis, and coronary artery disease. However, it is still unclear whether C pneumoniae plays a causal role in the pathogenesis of these conditions. Accordingly, we have performed a systematic dissection of the 3 coronary arteries on 33 postmortem subjects and studied the relationship in individual artery segments between the presence of C pneumoniae DNA and the severity of associated atherosclerosis.
Methods and Results—The prevalence of C pneumoniae DNA in arterial segments was determined by polymerase chain reaction (PCR) after controlling for the presence of PCR inhibitors. Atherosclerosis in each arterial segment was graded histologically with the Stary classification. C pneumoniae was detected by PCR in 78.8% of subjects, but there was no association between the presence of this DNA and cause of death or grade of atherosclerosis. When paired mild and severe atherosclerotic lesions within subjects were compared, mild lesions were as likely to be positive for C pneumoniae as severe lesions.
Conclusions—This study demonstrates that C pneumoniae can frequently be detected in atheromatous plaques in coronary arteries. However, its distribution did not correlate with severity or extent of disease.
Key Words: Chlamydia pneumoniae • atherosclerosis • coronary disease • infection
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Known risk factors account inadequately for the incidence of coronary artery disease (CAD),1 suggesting that other factors, such as infection, may be important.2 Chlamydia pneumoniae infection has been strongly implicated as a possible cause of atherosclerosis; most seroepidemiological and pathological studies have reported a positive association between prior or current infection with the organism and CAD.3 Furthermore, in 3 studies, viable C pneumoniae have been cultured from atherosclerotic tissue.4 5 6 However, there are problems with these data. First, many studies relied on the immunohistological detection of C pneumoniae antigen in atheroma. This method generally gives the highest prevalence of chlamydial infection but correlates poorly with detection of C pneumoniae DNA by polymerase chain reaction (PCR).4 5 7 8 9 Second, PCR-based studies have not been adequately controlled for the differential effect of PCR inhibitors. Third, the ubiquitous occurrence of atheroma from early age10 makes it difficult to select appropriately age-matched control vessels at similar risk of infection. Indeed, a number of studies either have not compared diseased with control vessels or have compared material from subjects of widely different ages.4 11 We have overcome this problem by determining the relationship between C pneumoniae infection and the severity of associated CAD within individuals within whom there can be no variation in exposure to blood-borne infection. The effect of tissue inhibitors on PCR sensitivity has been determined by use of internal amplification controls.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Specimen Collection
All 3 coronary arteries plus segments of the lung and myocardium were collected from 33 consecutive adult subjects at autopsy. Twenty-one subjects (63.6%) had died of causes related to CAD, and 12 had died of noncardiac causes. Postmortem examinations were performed within 48 hours of death, and the heart was aseptically removed before removal of other organs. In a laminar flow cabinet, each coronary artery was inspected, and 1-cm segments of the most and least diseased regions were sampled. Half of each segment was frozen in liquid nitrogen before detection of C pneumoniae DNA by PCR; the remainder was processed for histology.
Polymerase Chain Reaction
DNA was extracted from coronary arteries by conventional
proteinase K digestion and phenol-chloroform extraction; PCR was
performed in triplicate as previously described.12 To
check for PCR inhibitors in the extracted DNA, samples were
spiked with phage 
DNA and subjected to PCR with specific primers.
If inhibition was present, samples were diluted 10-fold. A nested
PCR was used to detect C pneumoniae,13 and
all positive products were confirmed by Southern
hybridization.12 Mock extraction controls and PCR-negative
controls were interspersed every 5 to 6 samples. A PCR-positive control
of DNA equivalent to 1 to 10 elementary bodies was used for every PCR
experiment.
Histology
Sections of coronary arteries adjacent to those studied
by PCR were stained with hematoxylin and eosin. Most sections were also
stained with Schmorl's stain for lipofuscin and with alizarin for
calcium. The severity of atherosclerosis was graded
with the Stary classification.14 This classification
ranges from grade 0 (normal) to grade 6 (plaque rupture, fissure, or
hemorrhage); grade 4 represents the earliest lesions
visible macroscopically.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Characteristics of the 33 recruited subjects are shown in Table 1
. Three coronary arteries
were obtained from 30 subjects and 2 coronary arteries were
from 3 subjects, for a total of 96 arteries. Two segments were
available from all but 5 of these arteries, resulting in 187 segments.
Segments with atherosclerosis of Stary grade 3 or less
were considered to have mild disease; those of grade 4 or greater were
considered to have moderate or severe disease. To assess the
reproducibility of Stary grading, 48 segments were recoded and then
regraded by the same specialist cardiac pathologist. Thirty-four
segments were graded identically on both occasions, with the remaining
segments differing by only 1 grade (
test, P=0.78). On
classifying into mild or severe groups, only 3 of 48 segments changed
groups on repeated grading.
|
Only 1 of 187 segments was Stary grade 0. Thirty-one subjects had 
1
atherosclerotic lesion in each artery of Stary grade 4 or more, and 26
of these subjects were positive for C pneumoniae DNA in
their coronary arteries. The remaining 2 subjects had mild
atherosclerosis of Stary grade 3 or less, and neither
had evidence of C pneumoniae DNA. There was no statistical
difference in age, sex, or cause of death in subjects with or without
C pneumoniae DNA in their coronary arteries.
Distribution of C pneumoniae in Coronary
Arteries
Subjects were as likely to have C pneumoniae in 1 (8 of
26) as in 2 (9 of 26) or 3 (9 of 26) coronary arteries.
Considering the individual arteries, 41 of 96 had both mild and
moderate or severely diseased segments. In these arteries, the mild
segments were just as likely to be positive for C pneumoniae
as the severe segments (Table 2; McNemar
test, P=1.0). Similarly, arteries that had mild disease only
were just as likely to have C pneumoniae as arteries that
had moderate or severe disease only (9 of 14 versus 20 of 36;
2 test, P=0.77). When all
arterial segments were considered as a group, no
correlation was observed between Stary classification and the presence
of C pneumoniae DNA (Table 3;
2 test, P=0.57). Thus, in 1 subject
with severe atherosclerosis throughout, C
pneumoniae was found at only 1 site, whereas in another subject
who had only mild disease, every arterial segment was
positive for C pneumoniae.
|
|
Effect of PCR Inhibitors
As anticipated, DNA samples extracted from coronary artery
segments with moderate or severe disease were more likely to contain
PCR inhibitors than samples extracted from mildly diseased
segments (40 of 114 versus 15 of 73; odds ratio [OR], 2.1; 95% CI,
1.1 to 4.1). Inhibition was associated with the presence of lipid (44
of 128 versus 10 of 54; OR, 2.3; CI, 1.1 to 5.0) and especially calcium
(42 of 103 versus 12 of 79; OR, 3.8; CI, 1.9 to 8.0) and was eliminated
in all but 1 case by 10-fold dilution. Sixteen of 55 inhibited samples
(29.1%) were positive for C pneumoniae compared with 52 of
132 uninhibited samples (39.4%; 2 test,
P=0.17). We tested each coronary artery segment on 3
separate occasions, but repeated PCR did not always give a
consistent result. Nine inhibited samples were positive 1 time;
7 samples, 2 times; and 0 samples, 3 times. For uninhibited samples, 34
were positive 1 time; 8 sample, 2 times; and 10 samples, 3 times.
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
A feature of this study was the careful control of PCR inhibition. DNA extracts of coronary arteries caused significant levels of PCR inhibition, associated particularly with severe atherosclerosis. Lipid and particularly calcium were the main sources of inhibition, illustrating the importance of using PCR inhibition controls when studying atheroma lesions of differing severity. A similar use of
DNA for this purpose was
recently reported by another group.15 Inhibition was
eliminated in all but 1 case by 10-fold dilution, but this was
associated with a reduction in chlamydial detection from 39% to 29%.
As reported by others,4 16 repeated testing of samples by
PCR did not always produce consistent results. We attribute
this to the low amounts of C pneumoniae DNA present in
coronary arteries, to the sampling errors arising from use of
small sample volumes, and to PCR inhibition. Our strategy of testing
all samples in triplicate should have reduced any resulting
underestimation of the prevalence of C pneumoniae. Unlike some other studies, we did not use immunocytochemistry (ICC) to detect C pneumoniae. In general, ICC gives a higher prevalence of C pneumoniae in coronary tissue than PCR.4 5 7 8 9 Unfortunately, it is not known whether this is due to better sensitivity or worse specificity. Careful control experiments in a specialist immunohistochemical laboratory with a range of C pneumoniae–specific monoclonal antibodies failed to convince us of the specificity of ICC for C pneumoniae in atheromatous plaque. Nonspecific binding of immunoglobulin in atheromatous plaque can be a problem, and other workers have commented on difficulties in interpreting ICC for C pneumoniae in atheromatous plaque.16 For C trachomatis genital infections, nucleic acid amplification–based methods are clearly established as the most sensitive method for detecting the organism. Furthermore, PCR enables positive results to be confirmed by sequencing or, as here, by hybridization.
Our main finding was that C pneumoniae DNA was common in
coronary arteries but that its distribution did not match the
extent or severity of atherosclerosis. Only 1 previous
study has looked for C pneumoniae at multiple sites from the
coronary tree.4 Although severity of
atherosclerosis was not graded, that study also found
that the distribution of C pneumoniae was patchy. C
pneumoniae has been detected in vessels not usually associated
with atherosclerosis, such as the internal mammary
artery and saphenous vein.12 17 Furthermore, in a
recent study of 60 Alaskan natives dying mainly of noncardiac causes
(mean age, 34.1 years), there was no difference in the severity of
atherosclerosis in subjects with or without C
pneumoniae infection, although a high C pneumoniae IgG
titer of 256 an average of 8 years before death was associated with
the presence of C pneumoniae in coronary
arteries.9 Other studies, however, have found that
C pneumoniae was more prevalent in severely diseased
than mildly diseased arterial segments. In 1 study, 15% of
carotid endarterectomy samples were found to be
positive for C pneumoniae by PCR, whereas the organism
could not be detected in macroscopically normal segments adjacent to
the diseased areas.18 Similarly, in an autopsy study
of young persons in which samples were age and sex
matched,7 C pneumoniae could not be found
in normal segments but was found in 2 of 11 segments with intimal
thickening and in 6 of 7 samples with atheroma.
In this study, the finding that C pneumoniae vascular infection is focal and not associated with the extent or severity of atherosclerosis does not disprove a role for the organism in CAD. After all, if C pneumoniae causes atherosclerosis, its presence would be expected to precede that of disease. Results from rabbit models indicate that intranasal inoculation with C pneumoniae either may result in aortic changes consistent with early atherosclerosis19 20 or may accelerate its development.21 However, if C pneumoniae merely colonizes diseased tissue and has no pathological role in CAD, its distribution would also be consistent with that observed here. The ability of C pneumoniae to induce or exacerbate atheroma in a population probably depends on more complex interactions with other factors than is generally appreciated. It is likely that the question of whether C pneumoniae causes or exacerbates CAD can be answered only by well-controlled animal studies and by large-scale antibiotic intervention trials.
|
Acknowledgments |
|---|
This work was supported by a grant from the British Heart Foundation and the Wessex Heartbeat Trust.
Received November 9, 1998; revision received March 10, 1999; accepted March 23, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Stewart AW. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease: the World Health Organization MONICA Project. Int J Epidemiol. 1994;23:505–516.
2. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risks factors for myocardial infarction. Eur Heart J. 1993;14(suppl K):12–16.
3. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430–436.[Medline] [Order article via Infotrieve]
4.
Ramirez JA. Isolation of Chlamydia
pneumoniae from the coronary artery of a patient with
coronary atherosclerosis: the Chlamydia
pneumoniae/Atherosclerosis Study Group. Ann
Intern Med. 1996;125:979–982.
5. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292–295.[Medline] [Order article via Infotrieve]
6.
Maass M, Bartels C, Engel PM, Mamat U, Sievers HH.
Endovascular presence of viable Chlamydia pneumoniae is a
common phenomenon in coronary artery disease. J Am
Coll Cardiol. 1998;31:827–832.
7.
Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW,
Benditt EP. Chlamydia pneumoniae (TWAR) in coronary
arteries of young adults (15–34 years old). Proc Natl Acad Sci
U S A. 1995;92:6911–6914.
8.
Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence
RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae
(TWAR) in atherosclerosis of the carotid artery.
Circulation. 1995;92:3397–3400.
9.
Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP,
Newman WP, Finley JC, Grayston JT. Confirmed previous infection with
Chlamydia pneumoniae (TWAR) and its presence in early
coronary atherosclerosis.
Circulation. 1998;98:628–633.
10. Tejada C, Strong JP, Montenegro MR, Restrepo C, Solberg LA. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968;18:509–526.[Medline] [Order article via Infotrieve]
11.
Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of
Chlamydia pneumoniae in aortic lesions of
atherosclerosis by immunocytochemical stain.
Arterioscler Thromb. 1993;13:1501–1504.
12.
Wong YK, Thomas M, Tsang VT, Gallagher PJ,
Ward ME. Prevalence of Chlamydia pneumoniae in
atherosclerotic and non-atherosclerotic blood vessels of patients
attending for redo and first time coronary artery bypass graft
surgery. J Am Coll Cardiol. 1999;33:152–156.
13. Cunningham AF, Johnston SL, Julious SA, Lampe FC, Ward ME. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998;11:345–349.[Abstract]
14. Stary HC. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol. 1992;421:277–290.[Medline] [Order article via Infotrieve]
15.
Pham DG, Madico GE, Quinn TC, Enzler MJ, Smith TF,
Gaydos CA. Use of lambda phage DNA as a hybrid internal control in a
PCR-enzyme immunoassay to detect Chlamydia pneumoniae.
J Clin Microbiol. 1998;36:1919–1922.
16. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957–962.[Medline] [Order article via Infotrieve]
17. Taylor-Robinson D, Ong G, Thomas BJ, Rose ML, Yacoub MH. Chlamydia pneumoniae in vascular tissues from heart-transplant donors. Lancet. 1998;351:1255. Letter.[Medline] [Order article via Infotrieve]
18. Maass M, Krause E, Engel PM, Kruger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology. 1997;48:699–706.
19. Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997;35:48–52.[Abstract]
20. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun. 1997;65:4832–4835.[Abstract]
21.
Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan
S, Schwobe ED, Carlquist JF. Infection with Chlamydia
pneumoniae accelerates the development of
atherosclerosis and treatment with azithromycin
prevents it in a rabbit model. Circulation. 1998;97:633–636.
This article has been cited by other articles:
 |
|
 |
|
  R. Mitusch, J. Luedemann, W. G. Wood, K. Berger, U. Schminke, M. Suter, C. Kessler, U. John, J. Rupp, M. Kentsch, et al. Asymptomatic Carotid Atherosclerosis Is Associated With Circulating Chlamydia pneumoniae DNA in Younger Normotensive Subjects in a General Population Survey Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 386 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Ieven and V. Y. Hoymans Involvement of Chlamydia pneumoniae in Atherosclerosis: More Evidence for Lack of Evidence J. Clin. Microbiol., January 1, 2005; 43(1): 19 - 24. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Zibaeenezhad, A. Amanat, A. Alborzi, and A. Obudi Relation of Chlamydia Pneumoniae Infection to Documented Coronary Artery Disease in Shiraz, Southern Iran Angiology, January 1, 2005; 56(1): 43 - 48. [Abstract] [PDF]
|
|
|
|
|
|
B. Maraha, H. Berg, M. Kerver, S. Kranendonk, J. Hamming, J. Kluytmans, M. Peeters, and A. van der Zee Is the Perceived Association between Chlamydia pneumoniae and Vascular Diseases Biased by Methodology? J. Clin. Microbiol., September 1, 2004; 42(9): 3937 - 3941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Y. Hoymans, J. M. Bosmans, D. Ursi, W. Martinet, F. L. Wuyts, E. Van Marck, M. Altwegg, C. J. Vrints, and M. M. Ieven Immunohistostaining Assays for Detection of Chlamydia pneumoniae in Atherosclerotic Arteries Indicate Cross-Reactions with Nonchlamydial Plaque Constituents J. Clin. Microbiol., July 1, 2004; 42(7): 3219 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Agmon, B. K. Khandheria, I. Meissner, T. M. Petterson, W. M. O'Fallon, T. J. H. Christianson, D. O. Wiebers, T. F. Smith, J. M. Steckelberg, and A. J. Tajik Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: A Population-Based transesophageal echocardiographic study J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1482 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Kalayoglu, P. Libby, and G. I. Byrne Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease JAMA, December 4, 2002; 288(21): 2724 - 2731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Apfalter, O. Assadian, F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, A. Makristathis, M. Nehr, M. L. Rotter, and A. M. Hirschl Reliability of Nested PCR for Detection of Chlamydia pneumoniae DNA in Atheromas: Results from a Multicenter Study Applying Standardized Protocols J. Clin. Microbiol., December 1, 2002; 40(12): 4428 - 4434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vainas, H. A.J.M. Kurvers, W. H. Mess, R. d. Graaf, R. Ezzahiri, J. H.M. Tordoir, G.-W. H. Schurink, C. A. Bruggeman, and P. J.E.H.M. Kitslaar Chlamydia pneumoniae Serology Is Associated With Thrombosis-Related but Not With Plaque-Related Microembolization During Carotid Endarterectomy Stroke, May 1, 2002; 33(5): 1249 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. C. Tondella, D. F. Talkington, B. P. Holloway, S. F. Dowell, K. Cowley, M. Soriano-Gabarro, M. S. Elkind, and B. S. Fields Development and Evaluation of Real-Time PCR-Based Fluorescence Assays for Detection of Chlamydiapneumoniae J. Clin. Microbiol., February 1, 2002; 40(2): 575 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Boman and M. R. Hammerschlag Chlamydia pneumoniae and Atherosclerosis: Critical Assessment of Diagnostic Methods and Relevance to Treatment Studies Clin. Microbiol. Rev., January 1, 2002; 15(1): 1 - 20. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Momiyama, R. Hirano, H. Taniguchi, H. Nakamura, and F. Ohsuzu Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection J. Am. Coll. Cardiol., September 1, 2001; 38(3): 712 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vink, M. Poppen, A. H. Schoneveld, P. J. M. Roholl, D. P. V. de Kleijn, C. Borst, and G. Pasterkamp Distribution of Chlamydia pneumoniae in the Human Arterial System and Its Relation to the Local Amount of Atherosclerosis Within the Individual Circulation, March 27, 2001; 103(12): 1613 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sander, K. Winbeck, J. Klingelhofer, T. Etgen, and B. Conrad Enhanced Progression of Early Carotid Atherosclerosis Is Related to Chlamydia pneumoniae (Taiwan Acute Respiratory) Seropositivity Circulation, March 13, 2001; 103(10): 1390 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Apfalter, F. Blasi, J. Boman, C. A. Gaydos, M. Kundi, M. Maass, A. Makristathis, A. Meijer, R. Nadrchal, K. Persson, et al. Multicenter Comparison Trial of DNA Extraction Methods and PCR Assays for Detection of Chlamydia pneumoniae in Endarterectomy Specimens J. Clin. Microbiol., February 1, 2001; 39(2): 519 - 524. [Abstract] [Full Text]
|
|
|
|
|
|
D. Tontsch, B. Noll, J. R. Schaefer, M. Herzum, B. Maisch, and B. Goeke Hyperinsulinemia, Lipoprotein (a), and Chlamydia pneumoniae Antibodies--Are They Risk Factors or Serologic Predictors for Progression of Coronary Artery Disease? Angiology, October 1, 2000; 51(10): 831 - 836. [Abstract] [PDF]
|
|
|
|
|
|
R. H. Ring and J. M. Lyons Failure To Detect Chlamydia pneumoniae in the Late-Onset Alzheimer's Brain J. Clin. Microbiol., July 1, 2000; 38(7): 2591 - 2594. [Abstract] [Full Text]
|
|
|
|
|
|
J. Sinisalo, K. Mattila, V. Valtonen, O. Anttonen, J. Juvonen, J. Melin, H. Vuorinen-Markkola, M. S. Nieminen, and for the Clarithromycin in Acute Coronary Syndrome Effect of 3 Months of Antimicrobial Treatment With Clarithromycin in Acute Non-Q-Wave Coronary Syndrome Circulation, April 2, 2002; 105(13): 1555 - 1560. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||